Westendpharma
Westendpharma GmbH is a Swiss healthcare consultancy that facilitates interaction between pharmaceutical/biotech companies and physicians through medical communications, opinion leader engagement, and campaign management across the drug lifecycle.
- Company typePrivate
- Founded2023
- HeadquartersZürich, Switzerland
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Westendpharma does
Westendpharma GmbH is a privately held Swiss healthcare consultancy founded in 2023 and headquartered at Unter Altstadt 3 in Zug, Switzerland. The firm provides B2B professional services to pharmaceutical and biotech companies, with a service portfolio spanning physician engagement, opinion leader training and publication support, campaign and initiative management, scientific therapy recommendation delivery, and end-to-end medication lifecycle support covering clinical development through market access. Its positioning emphasizes connecting patients with new therapies and innovations through a stable network of physicians and opinion leaders, built on personal, trust-based relationships developed over time.
Operationally, the company operates on a professional services revenue model, monetizing through contracts with enterprise pharma and biotech clients rather than selling products or licensing technology. It runs a direct enterprise field-sales motion, targeting medical and commercial leaders within client organizations, and emphasizes its independence and scientific credibility — staff are described as scientists from leading universities offering a "holistic perspective." The firm's technology footprint is modest and primarily infrastructural (Microsoft for IT/cloud, Google Analytics for web tracking); there is no proprietary software platform, no disclosed AI capabilities, and no published pricing. Leadership consists of two managing directors, Götz W. Gleichmann and Sven Christoph Winkler, and the company holds Swiss MWST registration (CHE-289.050.377) under commercial register number CH-170.4.021.219-8. No external funding, parent company, or M&A activity is disclosed in available materials.
Westendpharma firmographics
Firmographics- Name
- Westendpharma
- Legal name
- Westendpharma GmbH
- Website
- https://westendpharma.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Westendpharma GmbH is a Swiss healthcare consultancy that facilitates interaction between pharmaceutical/biotech companies and physicians through medical communications, opinion leader engagement, and campaign management across the drug lifecycle.
- Ownership category
- akta.pro rank
Where Westendpharma is headquartered
LocationHeadquarters
- HQ city
- Zürich
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
Westendpharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Healthcare Consultancy Services: Westendpharma provides professional services to pharmaceutical and biotech companies including scientific communication, opinion leader training, publication support, campaign management, and regulatory compliance facilitation. Revenue appears to be generated through service contracts with pharma/biotech clients rather than product sales.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Westendpharma product offering
Product offeringCore offering
Westendpharma is a pharmaceutical consultancy that facilitates and enriches interaction between pharmaceutical/biotech companies and physicians (healthcare professionals). It provides professional services across the entire drug lifecycle, including physician engagement, opinion leader training, publication support, campaign and initiative management, regulatory compliance facilitation, market access support, and scientific therapy recommendation services.
Product overview
Westendpharma operates as a single integrated service offering rather than a platform with separate modules. The company provides a comprehensive suite of physician engagement and pharmaceutical support services, including physician engagement facilitation, opinion leader training, publication support, campaign management, medication lifecycle support, and scientific therapy recommendations. These services work together to connect patients with innovations and appropriate physicians while supporting pharmaceutical and biotech companies in bringing new therapies to market. The company positions itself as a driver of new, innovative therapy standards, staffed by scientists from leading universities who serve as independent, holistic partners to physicians.
Differentiator
Problem solved
Functional benefit
Products and services
- Physician Engagement Services
- Opinion Leader Support Services
- Initiative Management and Campaign Services
- Medication Lifecycle Support
- Scientific Therapy Recommendation Services
Companies that use Westendpharma
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles1 record
Westendpharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Westendpharma partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights3 records
Westendpharma competitors and assessment
Company assessmentBroad incumbents
- IQVIA: Largest global CRO and pharma services platform with deep medical-communications, market-access, and real-world evidence capabilities. Westendpharma competes for the same enterprise pharma spend at the opposite end of the size spectrum.
- Syneos Health: Global biopharma services organization combining clinical development with commercial/medical communications. Directly competes with Westendpharma in physician engagement, opinion leader training, and market access support.
- McKinsey & Company (Pharma Practice): Global management consultancy with a large pharma and life sciences practice covering market access, R&D strategy, and commercial transformations. Represents the management-consulting alternative for Westendpharma's enterprise clients.
- ICON plc: Major CRO with significant commercial and consulting capabilities serving pharma/biotech. Comparable in customer base (enterprise pharma and biotech) and life-cycle service scope.
Direct peers
- Publicis Health: Large medical-communications and health advertising network serving pharma and biotech clients globally. Closely aligned with Westendpharma's core offerings around opinion leader engagement, publication support, and campaign execution.
- Ashfield Health (part of Inizio): Specialist medical communications and advisory firm focused on pharma/biotech clients. Directly comparable in scope (medical affairs, communications, market access) and target customers.
- Havas Health & You: Global health and wellness communications network with strong medical-affairs and market-access capabilities serving pharma clients. Directly comparable offering around physician engagement and scientific communications.
- Mind+Matter (Real Chemistry): Healthcare marketing and medical communications agency serving pharma and biotech. Comparable in enterprise pharma focus and integrated scientific communications + campaign model.
Regional players
- LEADING BIO: German-based medical communications and consulting firm serving pharma clients with medical-affairs, opinion leader, and publication support services. Comparable in DACH-region pharma consultancy focus and service mix.
- med 通 AG: Swiss medical communications and consulting firm serving pharma clients with medical-affairs support. Comparable as a DACH/Switzerland-based specialist of similar size and scope to Westendpharma.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Westendpharma social profiles
Digital presenceWestendpharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Westendpharma leadership team
Management profileNumber of profiles
Profiles2 records
Westendpharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Westendpharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Westendpharma
What does Westendpharma do?
Westendpharma is a pharmaceutical consultancy that facilitates and enriches interaction between pharmaceutical/biotech companies and physicians (healthcare professionals). It provides professional services across the entire drug lifecycle, including physician engagement, opinion leader training, publication support, campaign and initiative management, regulatory compliance facilitation, market access support, and scientific therapy recommendation services.
Is Westendpharma a public or private company?
Westendpharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Westendpharma founded?
Westendpharma was founded in 2023. It employs 51 to 100 people.
Where is Westendpharma based?
Westendpharma is headquartered in Zürich, Switzerland, in the Europe region.
How does Westendpharma make money?
One revenue line is on record: healthcare Consultancy Services.
Who are Westendpharma's main competitors?
Broad incumbents on record are IQVIA, Syneos Health, McKinsey & Company (Pharma Practice) and ICON plc. Direct peers are Publicis Health, Ashfield Health (part of Inizio), Havas Health & You and Mind+Matter (Real Chemistry). Regional players are LEADING BIO and med 通 AG.
Does Westendpharma have an API?
No public API is recorded for Westendpharma.